• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

女性射血分数保留型心力衰竭。

Heart Failure with Preserved Ejection Fraction in Women.

机构信息

Department of Internal Medicine, Division of Cardiology, Northwestern University, Feinberg School of Medicine, Chicago, IL, USA.

Department of Internal Medicine, Division of Cardiology, Northwestern University, Feinberg School of Medicine, Chicago, IL, USA.

出版信息

Heart Fail Clin. 2019 Jan;15(1):9-18. doi: 10.1016/j.hfc.2018.08.002.

DOI:10.1016/j.hfc.2018.08.002
PMID:30449384
Abstract

Heart failure with preserved ejection fraction (HFpEF) is an increasingly prevalent condition, particularly in women. Comorbidities, including older age, obesity, diabetes mellitus, hypertension, and hyperlipidemia, are risk factors and define phenotypic profiles of HFpEF in women. The condition has a relatively high burden of morbidity and mortality, with phenotypic profiles potentially characterizing risk of hospitalization and mortality. Based on limited data, nonpharmacologic and pharmacologic treatments may provide benefit; however, compelling evidence-based, disease-modifying treatments are needed. Many unanswered questions about HFpEF in women warrant further investigation to improve understanding of the disease and provide better patient care.

摘要

射血分数保留的心力衰竭(HFpEF)是一种日益普遍的病症,尤其在女性中更为常见。合并症,包括年龄较大、肥胖、糖尿病、高血压和高血脂,是风险因素,并定义了女性 HFpEF 的表型特征。这种疾病具有相对较高的发病率和死亡率负担,其表型特征可能表明住院和死亡的风险。基于有限的数据,非药物和药物治疗可能有益;然而,需要有强有力的循证、改变疾病的治疗方法。关于女性 HFpEF 的许多未解决的问题需要进一步研究,以提高对该疾病的认识并提供更好的患者护理。

相似文献

1
Heart Failure with Preserved Ejection Fraction in Women.女性射血分数保留型心力衰竭。
Heart Fail Clin. 2019 Jan;15(1):9-18. doi: 10.1016/j.hfc.2018.08.002.
2
Heart failure with preserved ejection fraction: strategies for disease management and emerging therapeutic approaches.射血分数保留的心力衰竭:疾病管理策略和新兴治疗方法。
Postgrad Med. 2021 Mar;133(2):125-139. doi: 10.1080/00325481.2020.1842620. Epub 2020 Dec 6.
3
Heart Failure with Reduced Ejection Fraction in Women: Epidemiology, Outcomes, and Treatment.女性射血分数降低型心力衰竭:流行病学、结局和治疗。
Heart Fail Clin. 2019 Jan;15(1):19-27. doi: 10.1016/j.hfc.2018.08.003. Epub 2018 Oct 24.
4
Heart Failure with Preserved Ejection Fraction in Older Adults.老年人心力衰竭伴射血分数保留
Heart Fail Clin. 2017 Jul;13(3):485-502. doi: 10.1016/j.hfc.2017.02.005. Epub 2017 May 6.
5
Obesity and heart failure with preserved ejection fraction: A growing problem.肥胖与射血分数保留的心力衰竭:日益严重的问题。
Trends Cardiovasc Med. 2018 Jul;28(5):322-327. doi: 10.1016/j.tcm.2017.12.003. Epub 2017 Dec 14.
6
Characteristics of Hospitalizations for Heart Failure with Preserved Ejection Fraction.射血分数保留的心力衰竭住院患者的特征
Am J Med. 2016 Jun;129(6):635.e15-26. doi: 10.1016/j.amjmed.2016.02.007.
7
Characterization of subgroups of heart failure patients with preserved ejection fraction with possible implications for prognosis and treatment response.射血分数保留的心力衰竭患者亚组特征及其对预后和治疗反应的潜在影响
Eur J Heart Fail. 2015 Sep;17(9):925-35. doi: 10.1002/ejhf.327. Epub 2015 Aug 6.
8
Heart failure with preserved ejection fraction: disease burden for patients, caregivers, and the health-care system.射血分数保留的心力衰竭:患者、照护者和医疗保健系统的疾病负担。
Postgrad Med. 2021 Mar;133(2):140-145. doi: 10.1080/00325481.2020.1842621. Epub 2020 Nov 27.
9
A novel paradigm for heart failure with preserved ejection fraction: comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation.一种新型射血分数保留心力衰竭模式:合并症通过冠状动脉微血管内皮炎症导致心肌功能障碍和重构。
J Am Coll Cardiol. 2013 Jul 23;62(4):263-71. doi: 10.1016/j.jacc.2013.02.092. Epub 2013 May 15.
10
Noncardiac comorbidities in heart failure with reduced versus preserved ejection fraction.射血分数降低与保留的心力衰竭患者的非心脏合并症
J Am Coll Cardiol. 2014 Dec 2;64(21):2281-93. doi: 10.1016/j.jacc.2014.08.036. Epub 2014 Nov 24.

引用本文的文献

1
Underpinnings of heart failure with preserved ejection fraction in women - From prevention to improving function. A co-publication with the American Journal of Preventive Cardiology and the Journal of Cardiac Failure.女性射血分数保留的心力衰竭的基础——从预防到改善功能。与《美国预防心脏病学杂志》和《心力衰竭杂志》合作出版。
Am J Prev Cardiol. 2025 Feb 19;23:100928. doi: 10.1016/j.ajpc.2025.100928. eCollection 2025 Sep.
2
Identifying and characterizing commercially insured patients with HFpEF with high vs low health care resource utilization.识别和描述高医疗资源利用率与低医疗资源利用率的射血分数保留的心力衰竭商业保险患者。
J Manag Care Spec Pharm. 2025 Aug;31(8):741-751. doi: 10.18553/jmcp.2025.31.8.741.
3
The Impact of Artificial Intelligence on Women's Cardiovascular Disease Care.
人工智能对女性心血管疾病护理的影响。
Curr Cardiol Rep. 2025 Jun 20;27(1):98. doi: 10.1007/s11886-025-02250-7.
4
Sex differences in the presentation, pathophysiology, and prognosis of heart failure with preserved ejection fraction.射血分数保留的心力衰竭在临床表现、病理生理学及预后方面的性别差异。
Heart Fail Rev. 2025 May 30. doi: 10.1007/s10741-025-10528-9.
5
Emerging risk factors for heart failure in younger populations: A growing public health concern.年轻人群中心力衰竭的新兴风险因素:日益受到关注的公共卫生问题。
World J Cardiol. 2025 Apr 26;17(4):104717. doi: 10.4330/wjc.v17.i4.104717.
6
Heart failure with preserved ejection fraction.射血分数保留的心力衰竭。
Nat Rev Dis Primers. 2024 Aug 14;10(1):55. doi: 10.1038/s41572-024-00540-y.
7
Empagliflozin protects against heart failure with preserved ejection fraction partly by inhibiting the senescence-associated STAT1-STING axis.恩格列净通过抑制衰老相关的 STAT1-STING 轴部分预防射血分数保留型心力衰竭。
Cardiovasc Diabetol. 2024 Jul 23;23(1):269. doi: 10.1186/s12933-024-02366-0.
8
Gender Effect on Clinical Profiles, Pharmacological Treatments and Prognosis in Patients Hospitalized for Heart Failure.性别对因心力衰竭住院患者的临床特征、药物治疗及预后的影响
J Clin Med. 2024 Feb 2;13(3):881. doi: 10.3390/jcm13030881.
9
Differences in Health-Related Quality of Life among Patients with Heart Failure.心力衰竭患者健康相关生活质量的差异。
Medicina (Kaunas). 2024 Jan 6;60(1):109. doi: 10.3390/medicina60010109.
10
The Correlation between Elevated HDL-Cholesterol, Body Mass Index, and Presence of Thyroid Nodules: A Retrospective Analysis.高密度脂蛋白胆固醇升高、体重指数与甲状腺结节存在之间的相关性:一项回顾性分析。
J Clin Med. 2023 Nov 29;12(23):7411. doi: 10.3390/jcm12237411.